These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 33338657)

  • 1. Endoscopic Assessment of Inflammatory Bowel Disease Activity in Clinical Trials.
    Khanna R; Ma C; Jairath V; Vande Casteele N; Zou G; Feagan BG
    Clin Gastroenterol Hepatol; 2022 Apr; 20(4):727-736.e2. PubMed ID: 33338657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endoscopic scoring indices for evaluation of disease activity in ulcerative colitis.
    Mohammed Vashist N; Samaan M; Mosli MH; Parker CE; MacDonald JK; Nelson SA; Zou GY; Feagan BG; Khanna R; Jairath V
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD011450. PubMed ID: 29338066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inter-observer agreement in endoscopic scoring systems: preliminary report of an ongoing study from the Italian Group for Inflammatory Bowel Disease (IG-IBD).
    Daperno M; Comberlato M; Bossa F; Biancone L; Bonanomi AG; Cassinotti A; Cosintino R; Lombardi G; Mangiarotti R; Papa A; Pica R; Rizzello F; D'Incà R; Orlando A
    Dig Liver Dis; 2014 Nov; 46(11):969-73. PubMed ID: 25154049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoscopic Disease Activity in Inflammatory Bowel Disease.
    Ket SN; Palmer R; Travis S
    Curr Gastroenterol Rep; 2015 Dec; 17(12):50. PubMed ID: 26650939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Training Programs on Endoscopic Scoring Systems for Inflammatory Bowel Disease Lead to a Significant Increase in Interobserver Agreement Among Community Gastroenterologists.
    Daperno M; Comberlato M; Bossa F; Armuzzi A; Biancone L; Bonanomi AG; Cassinotti A; Cosintino R; Lombardi G; Mangiarotti R; Papa A; Pica R; Grassano L; Pagana G; D'Incà R; Orlando A; Rizzello F;
    J Crohns Colitis; 2017 May; 11(5):556-561. PubMed ID: 28453758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-item Measures for Paediatric Inflammatory Bowel Diseases: The ABCs of All Those Acronyms.
    Ledder O; Turner D
    J Crohns Colitis; 2023 Jul; 17(7):1154-1168. PubMed ID: 36734262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum matrix metalloproteinase-9 concentration as a marker of disease activity in patients with inflammatory bowel disease.
    Shamseya AM; Hussein WM; Elnely DA; Adel F; Header DA
    Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e803-e809. PubMed ID: 34678857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Definition and evaluation of mucosal healing in clinical practice.
    Mazzuoli S; Guglielmi FW; Antonelli E; Salemme M; Bassotti G; Villanacci V
    Dig Liver Dis; 2013 Dec; 45(12):969-77. PubMed ID: 23932331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding Endoscopic Disease Activity in IBD: How to Incorporate It into Practice.
    Christensen B; Rubin DT
    Curr Gastroenterol Rep; 2016 Jan; 18(1):5. PubMed ID: 26759147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronological Review of Endoscopic Indices in Inflammatory Bowel Disease.
    Lee JS; Kim ES; Moon W
    Clin Endosc; 2019 Mar; 52(2):129-136. PubMed ID: 30130840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endoscopy in IBD: When and How?
    Daperno M
    Diagnostics (Basel); 2023 Nov; 13(22):. PubMed ID: 37998559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and Validation of a Patient-reported Score to Screen for Mucosal Inflammation in Inflammatory Bowel Disease.
    de Jong MJ; Roosen D; Degens JHRJ; van den Heuvel TRA; Romberg-Camps M; Hameeteman W; Bodelier AGL; Romanko I; Lukas M; Winkens B; Markus T; Masclee AAM; van Tubergen A; Jonkers DMAE; Pierik MJ
    J Crohns Colitis; 2019 Apr; 13(5):555-563. PubMed ID: 30476099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review on the current status and definitions of activity indices in inflammatory bowel disease: how to use indices for precise evaluation.
    Kishi M; Hirai F; Takatsu N; Hisabe T; Takada Y; Beppu T; Takeuchi K; Naganuma M; Ohtsuka K; Watanabe K; Matsumoto T; Esaki M; Koganei K; Sugita A; Hata K; Futami K; Ajioka Y; Tanabe H; Iwashita A; Shimizu H; Arai K; Suzuki Y; Hisamatsu T
    J Gastroenterol; 2022 Apr; 57(4):246-266. PubMed ID: 35235037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the spanish version of the inflammatory bowel disease questionnaire on ulcerative colitis and Crohn's disease.
    López-Vivancos J; Casellas F; Badia X; Vilaseca J; Malagelada JR
    Digestion; 1999; 60(3):274-80. PubMed ID: 10343142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoscopic scoring systems for inflammatory bowel disease: pros and cons.
    Tontini GE; Bisschops R; Neumann H
    Expert Rev Gastroenterol Hepatol; 2014 Jul; 8(5):543-54. PubMed ID: 24650249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low Fecal Calprotectin Correlates with Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohn's Disease.
    Zittan E; Kelly OB; Kirsch R; Milgrom R; Burns J; Nguyen GC; Croitoru K; Van Assche G; Silverberg MS; Steinhart AH
    Inflamm Bowel Dis; 2016 Mar; 22(3):623-30. PubMed ID: 26829408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neopterin concentration as an index of disease activity in Crohn's disease and ulcerative colitis.
    Husain N; Tokoro K; Popov JM; Naides SJ; Kwasny MJ; Buchman AL
    J Clin Gastroenterol; 2013 Mar; 47(3):246-51. PubMed ID: 23269308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a Core Outcome Set for Real-world Data in Inflammatory Bowel Disease: A European Crohn's and Colitis Organisation [ECCO] Position Paper.
    Hanzel J; Bossuyt P; Pittet V; Samaan M; Tripathi M; Czuber-Dochan W; Burisch J; Leone S; Saldaña R; Baert F; Kopylov U; Jäghult S; Adamina M; Arebi N; Gecse K
    J Crohns Colitis; 2023 Apr; 17(3):311-317. PubMed ID: 36190188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucosal healing as a target of therapy for colonic inflammatory bowel disease and methods to score disease activity.
    Walsh A; Palmer R; Travis S
    Gastrointest Endosc Clin N Am; 2014 Jul; 24(3):367-78. PubMed ID: 24975528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) expression and endoscopic activity in inflammatory bowel diseases.
    Jung YS; Park JJ; Kim SW; Hong SP; Kim TI; Kim WH; Cheon JH
    Dig Liver Dis; 2012 Nov; 44(11):897-903. PubMed ID: 22721842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.